Invivyd Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021
Cash & Equivalents	200.64	92.08	542.22
Short-Term Investments	0	279.92	49.19
Cash & Cash Equivalents	200.64	371.99	591.42
Cash Growth	-46.06%	-37.10%	-
Other Current Assets	24.24	4.93	25.29
Total Current Assets	224.88	376.92	616.71
Property, Plant & Equipment	4.13	6.06	0.08
Other Long-Term Assets	0.18	0.19	3.3
Total Long-Term Assets	4.3	6.25	3.38
Total Assets	229.18	383.17	620.09
Accounts Payable	7.95	1.52	5.78
Current Debt	1.44	1.56	0
Other Current Liabilities	40.9	21.96	56.28
Total Current Liabilities	50.29	25.03	62.06
Long-Term Debt	0.72	2.17	0
Other Long-Term Liabilities	0.7	0	0.01
Total Long-Term Liabilities	1.42	2.17	0.01
Total Liabilities	51.71	27.2	62.07
Total Debt	2.17	3.72	0
Debt Growth	-41.86%	-	-
Retained Earnings	-732.07	-533.43	-292.11
Comprehensive Income	-0.01	-0.27	-0.01
Shareholders' Equity	177.47	355.97	558.02
Net Cash / Debt	198.48	368.27	591.42
Net Cash / Debt Growth	-46.11%	-37.73%	-
Net Cash Per Share	1.81	3.40	13.88
Working Capital	174.59	351.89	554.65
Book Value Per Share	1.62	3.29	13.09

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).